ZIMVIE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.56 USD | +2.32% |
|
+5.51% | +4.56% |
| Jun. 25 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
| Jun. 25 | ZimVie Reportedly Working with Adviser to Explore Alternatives | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 243.7 | 471 | 506.5 | - | - |
| Enterprise Value (EV) 1 | 686.3 | 471 | 839.5 | 761.5 | 841.5 |
| P/E ratio | - | -1.19 x | -12.3 x | -26.3 x | 186 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 0.27 x | 0.54 x | 1.12 x | 1.1 x | 1.09 x |
| EV / Revenue | 0.75 x | 0.54 x | 1.85 x | 1.66 x | 1.81 x |
| EV / EBITDA | 5.6 x | 4.05 x | 13.9 x | 10.8 x | 11.1 x |
| EV / FCF | 84 x | 15.4 x | 12.6 x | 10.9 x | 10.5 x |
| FCF Yield | 1.19% | 6.5% | 7.92% | 9.21% | 9.51% |
| Price to Book | 0.32 x | - | - | - | - |
| Nbr of stocks (in thousands) | 26,088 | 26,536 | 27,289 | - | - |
| Reference price 2 | 9.340 | 17.75 | 18.56 | 18.56 | 18.56 |
| Announcement Date | 3/1/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,015 | 913.9 | 866.7 | 453.8 | 458.5 | 465 |
| EBITDA 1 | 131.6 | 122.5 | 116.4 | 60.5 | 70.6 | 76 |
| EBIT 1 | - | 60.85 | 61.8 | 34.7 | 41.5 | 45.5 |
| Operating Margin | - | 6.66% | 7.13% | 7.65% | 9.05% | 9.78% |
| Earnings before Tax (EBT) 1 | - | - | - | 74 | 75.7 | 77.72 |
| Net income 1 | -95.3 | - | -393.3 | -82.1 | -80.8 | 11.3 |
| Net margin | -9.39% | - | -45.38% | -18.09% | -17.62% | 2.43% |
| EPS 2 | - | - | -14.87 | -1.505 | -0.7050 | 0.1000 |
| Free Cash Flow 1 | - | 8.171 | 30.64 | 66.5 | 70.1 | 80 |
| FCF margin | - | 0.89% | 3.54% | 14.65% | 15.29% | 17.2% |
| FCF Conversion (EBITDA) | - | 6.67% | 26.32% | 109.92% | 99.29% | 105.26% |
| FCF Conversion (Net income) | - | - | - | - | - | 707.96% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/31/22 | 3/1/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 235.6 | 214.6 | 229.1 | 225.4 | 224.9 | 202.9 | 213.5 | 118.2 | 115.2 | 105.3 | 115.1 |
| EBITDA 1 | 33.85 | 29.38 | 28.05 | 32.08 | 29.72 | 25.84 | - | 12.45 | 15.8 | 14.3 | 18 |
| EBIT 1 | 19.18 | 14.05 | 11.49 | 18.92 | 14.25 | 12.24 | - | 7.593 | 8.8 | 7.3 | 11 |
| Operating Margin | 8.14% | 6.55% | 5.01% | 8.39% | 6.34% | 6.03% | - | 6.42% | 7.64% | 6.93% | 9.56% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | -0.9800 | 0.0300 | - | - | - | - | - | -0.2900 | -0.3800 | -0.4100 | -0.3000 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 5/5/22 | 11/9/22 | 3/1/23 | 5/3/23 | 8/2/23 | 11/1/23 | 2/28/24 | 5/8/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 443 | - | 333 | 255 | 335 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 3.612 x | - | 5.504 x | 3.612 x | 4.408 x |
| Free Cash Flow 1 | - | 8.17 | 30.6 | 66.5 | 70.1 | 80 |
| ROE (net income / shareholders' equity) | - | 4.33% | - | - | - | - |
| ROA (Net income/ Total Assets) | - | 2.76% | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | 28.90 | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 16.5 | 6.51 | 10.2 | 11.2 | 65 |
| Capex / Sales | - | 1.8% | 0.75% | 2.25% | 2.44% | 13.98% |
| Announcement Date | 3/31/22 | 3/1/23 | 2/28/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
18.56
USD
Average target price
19.37
USD
Spread / Average Target
+4.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.56% | 506M | |
| +75.67% | 12.57B | |
| -29.47% | 6.88B | |
| -2.53% | 6.06B | |
| +5.32% | 5.02B | |
| -18.75% | 4.69B | |
| +13.23% | 3.99B | |
| -22.33% | 3.65B | |
| -22.97% | 2.91B | |
| -2.23% | 1.98B |
- Stock Market
- Equities
- ZIMV Stock
- Financials ZimVie Inc.
